Fungus (1-3)-β-D-Glucan Test

This product is intended for the screening diagnosis of invasive fungal disease. It is used to provide rapid diagnostic reference for clinical invasive fungal infections through quantitative detection of (1-3)-β-D-glucan in the serum and Bronchoalveolar Lavage (BAL) fluid.

Recommended by the EORTC/MSG Consensus Group. As one of the mycological criteria for the diagnosis of invasive fungal disease.

ERA BIOLOGY, joint National Center for Clinical Laboratories etc., successfully drafted the industry standard of “Fungus (1-3)-β-D-Glucan Test” in 2017

Fungus (1-3) -β-D-Glucan (BG) is an unique element of fungal cell wall, when the fungus invading blood or deep tissue, BG can be released from the cell wall.

Fungus (1-3)-β-D-Glucan Test (Chromogenic Method) is used for screening and diagnosis for invasive fungal infection by quantitative detection of the Fungus (1-3) -β-D-Glucan content in human serum or BAL fluid sample.

Intended Use

Screening and Diagnosis for Invasive Fungal Infection

Advantage

• Quality control ensure the experimental accuracy
• Various specifications satisfy different requirements
• High negative predictive value 97.73%
• 5-8 days prior to clinical symptoms and imaging

Applicable Department

• Hematology Department
• Cancer Department
• Transplantation Department
• Neonatology Department
• Respiration Department
• ICU
• Infectious Department
• Dermatology Department

.